New gene shot could regrow knee cartilage and ease arthritis pain
Disease control
Not yet recruiting
This early-phase study tests a single injection of ICM-203, a gene therapy that delivers a gene to promote cartilage growth and reduce inflammation in the knee. About 18 adults with mild to moderate knee osteoarthritis will receive escalating doses to check safety and whether it …
Phase: PHASE1, PHASE2 • Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC